Evodiamine inactivates NF-κB and potentiates the antitumor effects of gemcitabine on tongue cancer both in vitro and in vivo
Qi Guo,1 Yanmei Liu,1 Jiayuan Zhao,1 Jing Wang,1 Yue Li,1 Yunqing Pang,1 Jian Chen,2 Jing Wang1 1Department of Periodontology, School of Stomatology, Lanzhou University, Lanzhou, Gansu, China; 2Department of Pediatric Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu, China Objecti...
Main Authors: | Guo Q, Liu Y, Zhao J, Wang J, Li Y, Pang Y, Chen J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-12-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/evodiamine-inactivates-nf-kappab-and-potentiates-the-antitumor-effects-peer-reviewed-article-OTT |
Similar Items
-
Emodin Reverses Gemcitabine Resistance of Pancreatic Cancer Cell Lines Through Inhibition of IKKβ/NF-κB Signaling Pathway
by: Tong H, et al.
Published: (2020-10-01) -
Evodiamine Induces Apoptosis in SMMC-7721 and HepG2 Cells by Suppressing NOD1 Signal Pathway
by: Xing-Xian Guo, et al.
Published: (2018-10-01) -
Antitumor activity of 2 new evodiamine derivatives against small-cell lung cancer cells in vitro
by: JIANG Xuejun, et al.
Published: (2019-05-01) -
Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma
by: Kejun Zhang, et al.
Published: (2012-01-01) -
Pharmacological Actions of Multi-Target-Directed Evodiamine
by: Zhanli Wang, et al.
Published: (2013-01-01)